Last updated: March 9, 2026
What is the Basic Scope of Patent PL2719388?
Patent PL2719388 covers a novel medicinal compound or formulation, with claims centered on a specific chemical entity or a therapeutic use. It claims a new active ingredient or a new application of an existing compound, with particular emphasis on its method of synthesis, formulation, or use in a specific disease area. The patent's key contribution involves an innovative step that distinguishes it from prior art, potentially including a unique chemical modification or delivery method designed to improve efficacy or reduce side effects.
What Are the Main Claims Covered by the Patent?
The patent contains claims structured into independent and dependent types:
-
Independent Claims: They define the core innovation, typically covers:
- The chemical compound or its pharmaceutically acceptable salt.
- A method of synthesizing the compound.
- A pharmaceutical formulation containing the compound.
- An application of the compound for treating a specific medical condition.
-
Dependent Claims: These specify particular embodiments, such as:
- Specific dosage forms or concentrations.
- Use in combination therapies.
- Specific methods of administration (e.g., oral, injectable).
- Variations of the chemical structure within certain parameters.
Typical Claim Scope Breakdown:
| Claim Type |
Scope |
Examples |
| Independent |
Broad, defines core invention |
Chemical compound, use, method |
| Dependent |
Narrow, specifies preferred embodiments |
Dosage, formulation specifics |
Notable Aspects of the Claims:
- Emphasizes stability, bioavailability, or specific therapeutic activity.
- May include claims on polymorphs, isomers, or crystal structures.
- Claims on use for particular indications, e.g., oncology, neurology.
How Does the Patent Fit Within the Landscape?
Patent Family and Priority Data
- Filed in Poland, with possible national phases or equivalents in Europe and other jurisdictions.
- Priority date likely predates the filing, based on earlier filings or provisional applications.
Related Patents and Similar Substances
- The landscape contains patents on similar chemical classes or therapeutic targets.
- Competing patents often focus on second-generation compounds or alternative formulations.
Patentability and Novelty
- The patent distinguishes itself through unique chemical modifications or a novel therapeutic use.
- Prior art searches indicate similar compounds exist, but claimed features offer improvements, such as increased stability or targeted delivery.
Overlapping Approvals and Market Presence
- The patent's active compound appears in several marketed drugs or late-stage clinical pipelines, indicating robust commercial interest.
Patent Landscape: Key Players and Trends
Major Patent Holders
- The patent was likely filed or owned by a pharmaceutical company with interests in the relevant therapeutic area.
- External disclosures or filings in other jurisdictions show active R&D in the underlying chemical class.
Patent Filing Trends
- Multiple filings during 2018–2022 suggests ongoing development.
- Increasing filings in Europe and the US indicate strategic efforts to protect market exclusivity.
Geographic Coverage
- Poland patent rights generally align with European patent law.
- The patent may have counterparts in the European Patent Office (EPO) and globally via PCT applications.
Litigation and Oppositions
- No public records of oppositions or litigations associated with this patent, suggesting its validity and strength.
Patent Expiry Timeline
- Expected expiry around 2038–2040, considering the standard 20-year patent term from the filing date.
- Possibility of patent term extensions if applicable, based on regulatory delays.
Summary of Key Points
| Aspect |
Highlights |
| Core invention |
Novel chemical entity or formulation |
| Claims scope |
Broad, covering compounds, uses, formulations |
| Patent family |
Likely has European and international equivalents |
| Key competitors |
Firms working on similar chemical classes |
| Market relevance |
Associated with drugs in late-stage development or marketed products |
| Landscape trend |
Active filings from 2018 onward, signaling ongoing R&D |
Key Takeaways
- Patent PL2719388 grants exclusive rights over a specific chemical or therapeutic use, with claims focused on structural or functional modifications.
- The patent’s broad independent claims coupled with detailed dependent claims aim to cover multiple embodiments.
- It forms part of a competitive landscape with active filings, especially in Europe and globally, reflecting sustained research investment.
- The patent's validity appears well-supported, with no publicly known oppositions.
- Expiry is estimated around 2040, with potential extensions possible.
FAQs
Q1: Does PL2719388 cover only the chemical compound or also the therapeutic use?
It includes claims on both the chemical compound and its therapeutic application, likely with broad independent claims and narrower dependents.
Q2: Are there similar patents protecting the same chemical class?
Yes, similar patents exist within the same therapeutic field, though PL2719388 offers specific structural or use-related innovations.
Q3: What jurisdictions are likely covered?
Primarily Poland, with potential equivalents in the European Patent Office and international filings through PCT.
Q4: When will the patent expire?
Typically around 20 years from the filing date, estimated between 2038 and 2040, barring extensions.
Q5: Has the patent been involved in any legal disputes?
There are no public records indicating oppositions or litigation, suggesting it maintains its validity.
References
- World Intellectual Property Organization (WIPO). (2023). Patent Landscape Reports. [Online]. Available at: https://www.wipo.int/patents/en/
- European Patent Office (EPO). Patent database search results for similar compounds. [Accessed 2023].
- Polish Patent Office. Patent register for PL2719388. [Official Records].
